RESUMEN
Coding variants in both myocilin (MYOC) and optineurin (OPTN) are reported risk factors for primary open-angle glaucoma (POAG) in many populations. This study investigated the contribution of MYOC and OPTN coding variants in Hispanics of Mexican descent with and without POAG. We conducted a case-control study of unrelated POAG cases and nonglaucomatous controls in a population of Hispanics of Mexican descent. Ascertainment criteria for POAG included the presence of glaucomatous optic neuropathy with associated visual field loss and the absence of secondary causes of glaucoma. Controls had normal optic nerves, visual fields and intraocular pressure. All coding exons of MYOC and OPTN were sequenced. The data set consisted of 88 POAG cases and 93 controls. A novel nonsynonymous coding variant (R7H) in the first exon of MYOC was identified. Other identified variants in MYOC and OPTN have been previously described and do not seem to contribute to POAG risk. This is the first comprehensive study of MYOC and OPTN in Hispanics of Mexican descent with POAG. Neither MYOC nor OPTN sequence variants seem to have a major role in the etiology of POAG in this population.
Asunto(s)
Proteínas del Citoesqueleto/genética , Proteínas del Ojo/genética , Variación Genética , Glaucoma de Ángulo Abierto/genética , Glicoproteínas/genética , Hispánicos o Latinos/genética , Americanos Mexicanos/estadística & datos numéricos , Factor de Transcripción TFIIIA/genética , Estudios de Casos y Controles , Proteínas de Ciclo Celular , Femenino , Humanos , Masculino , Proteínas de Transporte de Membrana , México/etnologíaRESUMEN
Excitation-contraction coupling, the process that regulates contractions by skeletal muscles, transduces changes in membrane voltage by activating release of Ca(2+) from internal stores to initiate muscle contraction. Defects in excitation-contraction coupling are associated with muscle diseases. Here we identify Stac3 as a novel component of the excitation-contraction coupling machinery. Using a zebrafish genetic screen, we generate a locomotor mutation that is mapped to stac3. We provide electrophysiological, Ca(2+) imaging, immunocytochemical and biochemical evidence that Stac3 participates in excitation-contraction coupling in muscles. Furthermore, we reveal that a mutation in human STAC3 is the genetic basis of the debilitating Native American myopathy (NAM). Analysis of NAM stac3 in zebrafish shows that the NAM mutation decreases excitation-contraction coupling. These findings enhance our understanding of both excitation-contraction coupling and the pathology of myopathies.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Fisura del Paladar/genética , Fisura del Paladar/fisiopatología , Acoplamiento Excitación-Contracción , Hipertermia Maligna/genética , Hipertermia Maligna/fisiopatología , Mutación/genética , Miotonía Congénita/genética , Miotonía Congénita/fisiopatología , Proteínas del Tejido Nervioso/genética , Proteínas de Pez Cebra/genética , Proteínas Adaptadoras Transductoras de Señales/química , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Alelos , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Sistema Nervioso Central/metabolismo , Sistema Nervioso Central/patología , Embrión no Mamífero/metabolismo , Humanos , Datos de Secuencia Molecular , Mutación Missense/genética , Miofibrillas/metabolismo , Miofibrillas/ultraestructura , Miotonía Congénita/patología , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/metabolismo , Especificidad de Órganos/genética , Fenotipo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Canal Liberador de Calcio Receptor de Rianodina/metabolismo , Natación , Tacto , Pez Cebra/embriología , Pez Cebra/genética , Proteínas de Pez Cebra/química , Proteínas de Pez Cebra/metabolismoRESUMEN
The molecular diagnosis of muscle disorders is challenging: genetic heterogeneity (>100 causal genes for skeletal and cardiac muscle disease) precludes exhaustive clinical testing, prioritizing sequencing of specific genes is difficult due to the similarity of clinical presentation, and the number of variants returned through exome sequencing can make the identification of the disease-causing variant difficult. We have filtered variants found through exome sequencing by prioritizing variants in genes known to be involved in muscle disease while examining the quality and depth of coverage of those genes. We ascertained two families with autosomal dominant limb-girdle muscular dystrophy of unknown etiology. To identify the causal mutations in these families, we performed exome sequencing on five affected individuals using the Agilent SureSelect Human All Exon 50 Mb kit and the Illumina HiSeq 2000 (2×100 bp). We identified causative mutations in desmin (IVS3+3A>G) and filamin C (p.W2710X), and augmented the phenotype data for individuals with muscular dystrophy due to these mutations. We also discuss challenges encountered due to depth of coverage variability at specific sites and the annotation of a functionally proven splice site variant as an intronic variant.